Literature DB >> 20960336

One year experience with 3.0 T intraoperative MRI in pituitary surgery.

David Netuka1, Václav Masopust, Tomáš Belšán, Filip Kramář, Vladimír Beneš.   

Abstract

A multifunctional surgical suite with intraoperative 3.0 T MRI (ioMRI) has been operating at the Central Military Hospital, Prague since April 2008. Our experiences over the past year and the effect of ioMRI on the extent of pituitary adenoma resection are evaluated. Eighty-six pituitary adenoma resections were performed in 85 patients with ioMRI in the first year of the ioMRI service. Pituitary adenoma suprasellar extension was present in 60 cases, invasion into cavernous sinus in 49 cases, and retrosellar growth in one case. The surgical goal was set before surgery: either a radical resection (49 cases) or a partial resection (37 cases). In the group of patients where a decision for a radical resection was taken the results are as follows: ioMRI confirmed radical resection in 69.4% of the cases; ioMRI disclosed unexpected adenoma residuum and further resection led to radical resection in 22.4%. In the group of patients where a decision for a partial resection was taken, the results are as follows: no further resection was perfomed after ioMRI in 51.3% of the cases and further resection was performed after ioMRI in 48.7% of the cases. ioMRI seems to be a valuable tool to increase the extent of pituitary adenoma resection.

Entities:  

Mesh:

Year:  2011        PMID: 20960336     DOI: 10.1007/978-3-211-99651-5_24

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  7 in total

Review 1.  Intraoperative magnetic resonance imaging during surgery for pituitary adenomas: pros and cons.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer
Journal:  Endocrine       Date:  2012-07-26       Impact factor: 3.633

2.  The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite.

Authors:  Hasan A Zaidi; Kenneth De Los Reyes; Garni Barkhoudarian; Zachary N Litvack; Wenya Linda Bi; Jordina Rincon-Torroella; Srinivasan Mukundan; Ian F Dunn; Edward R Laws
Journal:  Neurosurg Focus       Date:  2016-03       Impact factor: 4.047

Review 3.  iMRI During Transsphenoidal Surgery.

Authors:  Prashant Chittiboina
Journal:  Neurosurg Clin N Am       Date:  2017-08-18       Impact factor: 2.509

4.  Identification of tumor residuals in pituitary adenoma surgery with intraoperative MRI: do we need gadolinium?

Authors:  Georg Gohla; Benjamin Bender; Marcos Tatagiba; Jürgen Honegger; Ulrike Ernemann; Constantin Roder
Journal:  Neurosurg Rev       Date:  2019-11-14       Impact factor: 3.042

5.  Combined high-field intraoperative magnetic resonance imaging and endoscopy increase extent of resection and progression-free survival for pituitary adenomas.

Authors:  Peter T Sylvester; John A Evans; Gregory J Zipfel; Richard A Chole; Ravindra Uppaluri; Bruce H Haughey; Anne E Getz; Julie Silverstein; Keith M Rich; Albert H Kim; Ralph G Dacey; Michael R Chicoine
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

6.  Factors That Predict the Growth of Residual Nonfunctional Pituitary Adenomas: Correlations between Relapse and Cell Cycle Markers.

Authors:  Petr Matoušek; Petr Buzrla; Štefan Reguli; Jan Krajča; Jana Dvořáčková; Radim Lipina
Journal:  Biomed Res Int       Date:  2018-07-10       Impact factor: 3.411

7.  Impact of Intraoperative 3-Tesla MRI on Endonasal Endoscopic Pituitary Adenoma Resection and a Proposed New Scoring System for Predicting the Utility of Intraoperative MRI.

Authors:  Masahiro Tanji; Hiroharu Kataoka; Masahiro Kikuchi; Tatsunori Sakamoto; Fumihiko Kuwata; Mami Matsunaga; Takayuki Nakagawa; Yohei Mineharu; Yoshiki Arakawa; Kazumichi Yoshida; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-10-21       Impact factor: 1.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.